XML 59 R71.htm IDEA: XBRL DOCUMENT v3.19.3
SEGMENT INFORMATION (Summary of Reportable Segments) (Details)
$ in Thousands
3 Months Ended 9 Months Ended 21 Months Ended
Sep. 30, 2019
USD ($)
Sep. 30, 2018
USD ($)
Sep. 30, 2019
USD ($)
segment
Sep. 30, 2018
USD ($)
Sep. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
Financial information regarding the Company's reportable segments            
Number of reportable segments | segment     3      
Net sales $ 701,278 $ 665,775 $ 2,188,399 $ 2,079,733    
Acquisition related costs (1,355) (10,369) (2,636) (12,932)    
Total Restructuring Initiatives 6,019 23,852 17,286 48,002    
Depreciation and amortization 49,218 41,857 144,574 123,133    
Interest expense (8,898) (8,735) (26,868) (24,754)    
Interest income 957 1,537 3,738 6,306    
Income before Income Taxes 82,273 50,942 274,373 207,057    
Capital Expenditures     186,841 145,321    
Total Assets 3,465,139   3,465,139   $ 3,465,139 $ 3,377,735
Employee severance            
Financial information regarding the Company's reportable segments            
Total Restructuring Initiatives     7,566      
Business Transformation            
Financial information regarding the Company's reportable segments            
Total Restructuring Initiatives 6,000 23,900 17,300 48,000    
Capital Expenditures         $ 32,000  
Beauty + Home            
Financial information regarding the Company's reportable segments            
Net sales 328,182 341,760 1,037,921 1,088,469    
Adjusted EBITDA 41,475 42,174 143,411 141,155    
Total Restructuring Initiatives 5,341 18,854 14,869 38,501    
Pharma            
Financial information regarding the Company's reportable segments            
Net sales 269,251 227,515 823,891 698,851    
Adjusted EBITDA 96,546 84,516 295,553 250,709    
Total Restructuring Initiatives 168 2,008 381 3,596    
Food + Beverage            
Financial information regarding the Company's reportable segments            
Net sales 103,845 96,500 326,587 292,413    
Adjusted EBITDA 18,728 15,482 56,363 46,284    
Total Restructuring Initiatives 204 2,638 826 4,307    
Corporate & Other            
Financial information regarding the Company's reportable segments            
Adjusted EBITDA (9,943) (7,954) (33,328) (28,576)    
Total Restructuring Initiatives 306 352 1,210 1,598    
Operating segment            
Financial information regarding the Company's reportable segments            
Net sales 709,936 671,028 2,215,585 2,097,131    
Operating segment | Beauty + Home            
Financial information regarding the Company's reportable segments            
Net sales 333,870 346,040 1,056,626 1,103,664    
Operating segment | Pharma            
Financial information regarding the Company's reportable segments            
Net sales 271,608 227,691 830,679 699,105    
Operating segment | Food + Beverage            
Financial information regarding the Company's reportable segments            
Net sales 104,458 97,297 328,280 294,362    
Intersegment            
Financial information regarding the Company's reportable segments            
Net sales 8,658 5,253 27,186 17,398    
Intersegment | Beauty + Home            
Financial information regarding the Company's reportable segments            
Net sales 5,688 4,280 18,705 15,195    
Intersegment | Pharma            
Financial information regarding the Company's reportable segments            
Net sales 2,357 176 6,788 254    
Intersegment | Food + Beverage            
Financial information regarding the Company's reportable segments            
Net sales $ 613 $ 797 $ 1,693 $ 1,949